Clinical Trials
36 trialsStudying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
ADVICE
Filamon LTD
The Florida ASCENT Study
University of Florida
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
DETERMINE
Cancer Research UK
SMT-SL
Centre Hospitalier Universitaire de Nīmes
CAPTIV-8
British Columbia Cancer Agency
EARN
Washington University School of Medicine
ABILITY-1
Medicenna Therapeutics, Inc.
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
Revolution Medicines, Inc.
CheckMate 76U
Bristol-Myers Squibb
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
Ohio State University Comprehensive Cancer Center
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Lumos Pharma
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Stanford University
Tenatumomab
sigma-tau i.f.r. S.p.A.
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Santa Maria Biotherapeutics
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
BIND Therapeutics
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Emory University
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Calando Pharmaceuticals
Comparison of Standard of Care or Treatment on Protocol
New Mexico Cancer Research Alliance
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Hoag Memorial Hospital Presbyterian
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients
Netherlands Open University
Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors
Fujian Longhua Pharmaceutical Co. Ltd
Study of NS-9 in Patients With Liver Metastases
NS Pharma, Inc.